BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 36015231)

  • 21. Recent breakthroughs in gene therapy for inherited retinal degeneration.
    Revere KE; Chung DC
    Discov Med; 2009 Oct; 8(42):125-9. PubMed ID: 19833058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular Gene Therapy: A Literature Review With Focus on Current Clinical Trials.
    Wasnik VB; Thool AR
    Cureus; 2022 Sep; 14(9):e29533. PubMed ID: 36312652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy strategies in glaucoma and application for steroid-induced hypertension.
    Borrás T
    Saudi J Ophthalmol; 2011 Oct; 25(4):353-62. PubMed ID: 23960949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis.
    Le Meur G; Lebranchu P; Billaud F; Adjali O; Schmitt S; Bézieau S; Péréon Y; Valabregue R; Ivan C; Darmon C; Moullier P; Rolling F; Weber M
    Mol Ther; 2018 Jan; 26(1):256-268. PubMed ID: 29033008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosafety challenges for use of lentiviral vectors in gene therapy.
    Rothe M; Modlich U; Schambach A
    Curr Gene Ther; 2013 Dec; 13(6):453-68. PubMed ID: 24195603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Future Looks Brighter After 25 Years of Retinal Gene Therapy.
    Auricchio A; Smith AJ; Ali RR
    Hum Gene Ther; 2017 Nov; 28(11):982-987. PubMed ID: 28825330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
    Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
    Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospectives for gene therapy of retinal degenerations.
    Thumann G
    Curr Genomics; 2012 Aug; 13(5):350-62. PubMed ID: 23372421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study.
    Campochiaro PA; Lauer AK; Sohn EH; Mir TA; Naylor S; Anderton MC; Kelleher M; Harrop R; Ellis S; Mitrophanous KA
    Hum Gene Ther; 2017 Jan; 28(1):99-111. PubMed ID: 27710144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease.
    Marquez Loza LI; Yuen EC; McCray PB
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30875857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-transduction of lentiviral and adenoviral vectors for co-delivery of growth factor and shRNA genes in mesenchymal stem cells-based chondrogenic system.
    Zhang F; Yao Y; Su K; Fang Y; Citra F; Wang DA
    J Tissue Eng Regen Med; 2015 Sep; 9(9):1036-45. PubMed ID: 23193077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.
    Kong J; Kim SR; Binley K; Pata I; Doi K; Mannik J; Zernant-Rajang J; Kan O; Iqball S; Naylor S; Sparrow JR; Gouras P; Allikmets R
    Gene Ther; 2008 Oct; 15(19):1311-20. PubMed ID: 18463687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lentiviral vector-mediated RNA silencing in the central nervous system.
    Hutson TH; Foster E; Moon LD; Yáñez-Muñoz RJ
    Hum Gene Ther Methods; 2014 Feb; 25(1):14-32. PubMed ID: 24090197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Developments in gene delivery vectors for ocular gene therapy].
    Khabou H; Dalkara D
    Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on ocular gene therapy and advances in treatment of inherited retinal diseases and exudative macular degeneration.
    Garoon RB; Stout JT
    Curr Opin Ophthalmol; 2016 May; 27(3):268-73. PubMed ID: 26918787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and Pattern of Worldwide Ocular Gene Therapy Clinical Trials up to 2022.
    Ameri H; Kesavamoorthy N; Bruce DN
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
    Morris KV; Rossi JJ
    Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vector platforms for gene therapy of inherited retinopathies.
    Trapani I; Puppo A; Auricchio A
    Prog Retin Eye Res; 2014 Nov; 43():108-28. PubMed ID: 25124745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.
    Sauer AV; Di Lorenzo B; Carriglio N; Aiuti A
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):527-34. PubMed ID: 25207699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy.
    Coroadinha AS
    Methods Mol Biol; 2022; 2521():297-315. PubMed ID: 35733005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.